Medical/Pharmaceuticals
Synapse Medicine Initiates Multi-Site Implementation Study with Leading U.S Hospitals
* Synapse Medicine clinical decision support technology analyzes drug-related risks based on each patient's clinical characteristics and will be studied for its impact on inpatient pharmacist efficacy and efficiency. * The Synapse Medicine medication reconciliation tool will be deployed throu...
2022-10-07 07:05
2796
United Imaging Installs Broward County's First uMI 550 at Holy Cross Health in Fort Lauderdale
Holy Cross procured the uMI 550 to "go digital" and continue to innovate for its community. HOUSTON, Oct. 6, 2022 /PRNewswire/ -- United Imaging, a global manufacturer of medical imaging equipment, announced the installation ofBroward County's first uMI 550 at Holy Cross Health, a member of Trin...
2022-10-07 00:00
1945
TauRx Announces Results from Phase 3 Alzheimer's Disease Study, LUCIDITY, Assuring Path for Regulatory Submissions
* For people with early Alzheimer's (MCI), HMTM treatment resulted in sustained improvement in cognition over pre-treatment baseline, and normalisation of brain atrophy to a rate similar to healthy individuals * For people with mild to moderate Alzheimer's, HMTM stabilised cognition and funct...
2022-10-06 18:00
2626
AWARD-WINNING SKINPEN® PRECISION ANNOUNCES NEW AND EXPANDED APPROVED INDICATIONS
Solidifies Status as the Leading, Most Advanced Skin Remodeling Treatment System DALLAS, Oct. 6, 2022 /PRNewswire/ -- Crown Aesthetics ("Crown"), a division of Crown Laboratories and inventors of the award-winningSkinPen Precision, announced today that its revolutionary device has received three ...
2022-10-06 14:30
2214
Cytiva strengthens cell line development with CEVEC acquisition
* Viral vector manufacturing and cell line development are keystone technologies in the making of gene therapies * 46 scientific experts based in Cologne, Germany, join the Cytiva team in the genomic medicine space * Cytiva customers will have immediate access to technologies that solve som...
2022-10-06 14:00
2293
Servier unveils its 2030 ambition and reveals a new visual identity
* A new ambition by 2030 to accelerate its transformation dynamic * A visual identity, a marker of the successful transformation of the Group, its ambitions and its renewal PARIS, Oct. 6, 2022 /PRNewswire/ -- Servier today unveils its 2030 ambition as well as a new visual identity that reflec...
2022-10-06 13:30
2627
ASTRAZENECA, First Organization in Egypt receiving Best place to work for Millennials Award
CAIRO, Oct. 5, 2022 /PRNewswire/ -- AstraZeneca Egypt, was recently certified as a Best Place to Work for Millennials marking it the first organization in Egypt to receive such award. The certification is based on an HR analysis of the company policies focusing on Millennials and an anonymous emp...
2022-10-05 22:59
1802
Ascletis Announces Dosing of the First Patient in Phase II Clinical Trial of THRβ Agonist ASC41 for 52-Week Treatment of Liver Biopsy-Proven NASH
-- ASC41 is ranking first in China and third in the world in terms of clinical progress as a thyroid hormone receptor β (THRβ) agonist drug candidate for non-alcoholic steatohepatitis (NASH). ASC41 Phase II clinical trial is currently the most advanced 52-week Phase II clinical trial which is in...
2022-10-05 08:10
4003
Transcenta Received IND Clearance from FDA for Its Best-In-Class MASP2 Targeting Antibody TST004 for the Treatment of IgA Nephropathy
SUZHOU, China, Oct. 5, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that TST004, its best...
2022-10-05 08:00
3357
HAVAS HEALTH & YOU APPOINTS PAUL PFLEIDERER AS PRESIDENT OF HAVAS LIFE NEW YORK
NEW YORK, Oct. 4, 2022 /PRNewswire/ -- As the rapid evolution of the health and wellness sector continues to necessitate innovative thinking and activation across the industry, Havas Health & You today announced that it has appointed seasoned strategic leaderPaul Pfleiderer as President of Havas ...
2022-10-04 21:00
1625
RevitaLash® Cosmetics Champions Breast Cancer Awareness, Research, and Support Worldwide with 2022 Pink Program Announcement
The Mission-Driven Lash & Brow Leader Expands Its Year-Round Breast Cancer Awareness Efforts Globally VENTURA, Calif., Oct. 4, 2022 /PRNewswire/ -- RevitaLash® Cosmetics is proud to announce the company's annual 2022 Pink Program campaign. In honor of Breast Cancer Awareness month, RevitaLash® C...
2022-10-04 20:43
5429
HanAll's Second FcRn Inhibitor HL161ANS to be Added to the Development Program of its Licensed Partner
* Immunovant, a HanAll's licensed partner, unveiled its plan to develop a new FcRn inhibitor, HL161ANS (also known as IMVT-1402) * In animal studies, HL161ANS indicated deep IgG reductions similar to batoclimab with no or minimal impact on albumin and LDL cholesterol level * Batoclimab (form...
2022-10-04 19:00
2261
GHA's HealthStars EXCELerator: Driving Business and Healthcare Outcomes through Innovation
WEST PALM BEACH, Fla., Oct. 4, 2022 /PRNewswire/ -- Global Healthcare
Accreditation (GHA) announces the launch of HealthStars EXCELerator, a program
designed to accelerate innovation and maximize a businesses' opportunity for
success in the global healthcare space.
2022-10-04 18:00
3114
Pacertool Establishes World-Class Scientific Advisory Board
The Scientific Advisory Board Will Develop the Company Clinical Trial Strategy, Ensure Alignment with Current Trends in Cardiac Pacing for Heart Failure Patients and Provide Input to the Pacertool Innovation Pipeline. OSLO, Norway, Oct. 4, 2022 /PRNewswire/ -- Pacertool AS, a Norwegian emerging ...
2022-10-04 16:29
2029
Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Game-changing Versatilities in Human Biochemistry
OKAYAMA, Japan, Oct. 4, 2022 /PRNewswire/ -- Hayashibara Co., Ltd., a member of Nagase Group and headquartered in Okayama City, westernJapan, hosted the 24th Trehalose Symposium, with the support of the Japanese Society of Applied Glycoscience, onSeptember 8, 2022. Photo: https://kyodonewsprwir...
2022-10-04 14:00
1762
Duality announced the appointment of Dr. Yver as Chairman of SAB
PRINCETON, N. J. and SHANGHAI, SUZHOU, China, Oct. 3, 2022 /PRNewswire/ -- Duality Biotherapeutics, Inc. ("Duality" or "the Company") today announced the appointment of Dr.Antoine Yver as Chairman of SAB. Dr. Antoine Yver will provide strategic advice and guidance for the Company's R&D and pipeli...
2022-10-03 22:00
2475
DetectedX to Provide Free Access to Radiology Online Learning Platform to Radiology Across Borders to Enhance Global Charity's Teaching Initiatives
Radiology Across Borders will Promote Access to DetectedX's On-Demand, Web-Based Educational Platform to Clinicians from Developing Nations to Improve Diagnostic Accuracy SYDNEY, Oct. 3, 2022 /PRNewswire/ -- DetectedX announced today that it will provide free access to its Radiology Online Learn...
2022-10-03 20:00
2431
Estrella Biopharma, Inc., a biopharmaceutical company to Become a Publicly Traded Company Via Merger with TradeUP Acquisition Corp.
NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Estrella Biopharma, Inc. ("Estrella"), a preclinical-stage biopharmaceutical company focusing on cancer therapeutics, and TradeUP Acquisition Corp. ("TradeUP") (NASDAQ: UPTD), a publicly traded special purpose acquisition company, today announced that they h...
2022-10-03 19:27
4160
Kira Pharmaceuticals Receives FDA Clearance of IND Application for Phase 2 Evaluation of KP104 in Systemic Lupus Erythematosus Associated Thrombotic Microangiopathy (SLE-TMA)
Phase 1 supporting data indicated an encouraging profile and confirmed the dual mechanism of action achieved through targeting both the alternative and terminal complement pathways CAMBRIDGE, Mass., Oct. 3, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering tran...
2022-10-03 19:00
2824
Award Presentation of the "2022 Most Innovative Enterprise Award"
Beyond Creative, Be Innovative HONG KONG, Oct. 3, 2022 /PRNewswire/ -- BUSINESS INNOVATOR successfully held the "2022 Most Innovative Enterprise Award" presentation ceremony on 30th September 2022 at the Island Shangri-La Hotel. The ceremony acknowledges businesses demonstrating remarkable contr...
2022-10-03 17:51
7499
Week's Top Stories
Most Reposted
TD Brings its Global Asset Management Businesses Under One Name
[Picked up by 1168 media titles]
2026-11-02 20:00OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1129 media titles]
2026-11-05 06:52Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1082 media titles]
2026-11-03 22:00Fintech OPay Raises $304 Million Ahead of NYSE Debut: NYSE Content Update
[Picked up by 1079 media titles]
2026-10-30 22:34
H.E. Ahmed Al-Khateeb, Saudi Minister of Tourism, Inaugurates Saudi Land at WTM London 2026, Reinforcing Saudi's Commitment to Global Travel Trade
[Picked up by 1067 media titles]
2026-11-04 07:31
Most Read
1B views since June: Coda and TikTok Gaming turn content into commerce
2026-11-02 09:35
62639
Airbrush Upgrades AI Image Enhancer With 16K Output and Batch Processing for Up to 50 Images
2026-11-03 02:00
58637
iQIYI Launches China's First AI Film Studio in Shanghai, with Inaugural Title "Cop in Trouble" in Production
2026-11-02 09:52
55754
Korean Derma Skincare Brand MDP+ Launches at Nordstrom
2026-11-03 00:30
25227
